EP Patent

EP1886665A1 — Gastro retentive delivery system

Assigned to Boehringer Ingelheim Pharma GmbH and Co KG · Expires 2008-02-13 · 18y expired

What this patent protects

The present invention is directed to pharmaceutical composition for the manufacture of a gastro retentive drug delivery system comprising a pharmaceutical formulation and an application condition of the same.

USPTO Abstract

The present invention is directed to pharmaceutical composition for the manufacture of a gastro retentive drug delivery system comprising a pharmaceutical formulation and an application condition of the same.

Drugs covered by this patent

pramipexole-dihydrochloride (PRAMIPEXOLE DIHYDROCHLORIDE)

Patent Metadata

Patent number: EP1886665A1
Jurisdiction: EP
Classification: —
Expires: 2008-02-13
Drug substance claim: No
Drug product claim: No
Assignee: Boehringer Ingelheim Pharma GmbH and Co KG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.